Raymond James Trust N.A. Purchases 132 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Raymond James Trust N.A. boosted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 4.8% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 2,905 shares of the company’s stock after purchasing an additional 132 shares during the quarter. Raymond James Trust N.A.’s holdings in HealthEquity were worth $238,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. International Assets Investment Management LLC purchased a new position in shares of HealthEquity in the second quarter worth $35,000. Paladin Wealth LLC bought a new position in HealthEquity during the 3rd quarter valued at about $39,000. GAMMA Investing LLC boosted its holdings in shares of HealthEquity by 114.8% during the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after acquiring an additional 318 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of HealthEquity in the second quarter worth approximately $73,000. Finally, 1620 Investment Advisors Inc. purchased a new position in shares of HealthEquity during the third quarter valued at approximately $112,000. 99.55% of the stock is currently owned by institutional investors.

Insider Activity

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now owns 3,784 shares in the company, valued at $363,642.40. This trade represents a 21.54 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 10,536 shares of company stock worth $884,517 over the last quarter. Insiders own 2.20% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on HQY. Bank of America raised their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Barrington Research reaffirmed an “outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a report on Friday, September 20th. BTIG Research upped their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. JMP Securities reissued a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Finally, The Goldman Sachs Group started coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target for the company. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average target price of $107.23.

HealthEquity Trading Down 1.1 %

Shares of HealthEquity stock opened at $102.47 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The company has a fifty day moving average of $89.25 and a 200 day moving average of $82.46. The company has a market capitalization of $8.95 billion, a P/E ratio of 85.39, a P/E/G ratio of 1.62 and a beta of 0.52. HealthEquity, Inc. has a fifty-two week low of $62.10 and a fifty-two week high of $105.82.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million during the quarter, compared to analysts’ expectations of $284.48 million. On average, sell-side analysts anticipate that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.